FDA approves Stivarga for GIST

Familiar with GIST?
gastrointestinal stromal tumors
GIST

Today, the FDA announced the approval of Stivarga (regorafenib) to treat patients with advanced gastrointestinal stromal tumors (GIST) that cannot be surgically removed and no longer respond to other FDA-approved treatments for this disease.

Learn more here.